Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Accumulated Depreciation & Amortization (2016 - 2021)

Edesa Biotech's Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $33853.0 for Q3 2021.

  • For Q3 2021, Accumulated Depreciation & Amortization rose 32.6% year-over-year to $33853.0; the TTM value through Sep 2021 reached $33853.0, up 32.6%, while the annual FY2021 figure was $33853.0, 32.6% up from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2021 was $33853.0 at Edesa Biotech, up from $31944.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $188000.0 in Q3 2018 and bottomed at -$42089.0 in Q2 2019.
  • The 5-year median for Accumulated Depreciation & Amortization is $38926.5 (2018), against an average of $64628.9.
  • The largest annual shift saw Accumulated Depreciation & Amortization crashed 129.43% in 2019 before it surged 891.37% in 2020.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $49000.0 in 2017, then dropped by 10.2% to $44000.0 in 2018, then tumbled by 93.68% to $2780.0 in 2019, then soared by 891.37% to $27560.0 in 2020, then grew by 22.83% to $33853.0 in 2021.
  • Per Business Quant, the three most recent readings for EDSA's Accumulated Depreciation & Amortization are $33853.0 (Q3 2021), $31944.0 (Q2 2021), and $29464.0 (Q1 2021).